PUBLIC CONTRACT · 2024
Abiraterona 500 mg comp, Ustecinumab 45 mg/0.5 ml sol inj ser 0.5 ml SC e Ustecinumab 90 mg/1 ml sol inj ser 1 ml SC
- Contract value
- €0.00
- Signed on
- 3 August 2024
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 10865341PUBLISHED SUBJECT
Abiraterona 500 mg comp, Ustecinumab 45 mg/0.5 ml sol inj ser 0.5 ml SC e Ustecinumab 90 mg/1 ml sol inj ser 1 ml SC
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Lisboa, Lisboa
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- JANSSEN-CILAG FARMACÊUTICA, LDA · Tax ID 500189412
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €0.00
- Procedure base price
- €819,352.35
- Total effective price
- Not reported on Portal BASE
- Publication date
- 10 August 2024
- Award date
- 25 July 2024
- Signing date
- 3 August 2024
- Performance period
- 136 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- 671/2023 - Concurso público internacional para formação do acordo quadro de medicamentos diversos
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7172097
- Records on Portal BASE
- Recorded 2 times on Portal BASE with the same content. This page and pages 10865328 count as a single contract in lists and totals; we keep them all.
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.